LAUSR

PURPOSE A large part of the national opioid epidemic has been tied to prescription opioids, leading to a push to reduce or eliminate their use when feasible. The objective of this study was to evaluate outcomes of implementing an Enhanced Recovery After Surgery (ERAS) protocol for patients undergoing ureteroscopic stone treatment with stent placement geared toward minimizing opioid use. MATERIALS AND METHODS We performed a pre-post study concerning a process improvement project of consecutive patients undergoing ureteroscopic stone treatment with stent placement utilizing a novel ERAS protocol. A lead-in period with patients managed conventionally with opioids was performed prior to implementation of the ERAS protocol. Data regarding opioid utilization, postoperative outcomes, and patient-reported outcomes including PROMIS (Patient-Reported Outcomes Measurement System) were compared between groups. RESULTS There were 28 pre-ERAS patients and 52 ERAS-managed patients. Patients discharged with an opioid prescription decreased from 93% to 0% (p<0.05). Mean total Morphine Milligram Equivalent decreased from 60.1 +/- 41 to 7.7 +/- 26 (p<0.05). There was no significant difference noted for postoperative calls for pain in the pre-ERAS vs ERAS groups (25% vs 19%, p=0.9) or in unscheduled provider encounters (0% vs 4%, p=0.46). There were no clinically significant differences between groups on patient-reported measures. CONCLUSIONS Implementation of an ERAS protocol for ureteroscopic stone treatment resulted in a significant reduction in perioperative opioids, a total reduction in discharge opioid prescriptions, and a nearly 90% reduction in total 30-day postoperative opioid prescribing with no adverse effects on recovery or increase in postoperative clinical encounters.